Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Guttman

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Brain : a Journal of Neurology|January 21, 2009
Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's diseaseIsabelle Boileau, Mark Guttman, Pablo Rusjan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 29, 2008
Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASBIsabelle Boileau, Jerry J Warsh, Mark Guttman, et al.
Brain Research|February 3, 2007
Sepiapterin reductase expression is increased in Parkinson's disease brain tissueJennifer E Tobin, Jing Cui, Jemma B Wilk, et al.
Brain : a Journal of Neurology|November 12, 2009
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigationJunchao Tong, Henry Wong, Mark Guttman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2015
[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disordersDoris E Payer, Mark Guttman, Stephen J Kish, et al.
Plos Currents|September 20, 2011
Assessment of Day-to-Day Functioning in Prodromal and Early Huntington DiseaseAnthony L Vaccarino, Terrence Sills, Karen E Anderson, et al.
The Journal of Clinical Investigation|August 30, 2013
Metabolic network as a progression biomarker of premanifest Huntington's diseaseChris C Tang, Andrew Feigin, Yilong Ma, et al.
Journal of Huntington'S Disease|July 4, 2016
Health Care Delivery Practices in Huntington's Disease Specialty Clinics: An International SurveyJan C Frich, Daniela Rae, Richard Roxburgh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 22, 2019
Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studiesJunchao Tong, Belinda Williams, Pablo M Rusjan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriersAnthony L Vaccarino, Karen Anderson, Beth Borowsky, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Brain : a Journal of Neurology|January 21, 2009
Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's diseaseIsabelle Boileau, Mark Guttman, Pablo Rusjan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 29, 2008
Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASBIsabelle Boileau, Jerry J Warsh, Mark Guttman, et al.
Brain Research|February 3, 2007
Sepiapterin reductase expression is increased in Parkinson's disease brain tissueJennifer E Tobin, Jing Cui, Jemma B Wilk, et al.
Brain : a Journal of Neurology|November 12, 2009
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigationJunchao Tong, Henry Wong, Mark Guttman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2015
[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disordersDoris E Payer, Mark Guttman, Stephen J Kish, et al.
Plos Currents|September 20, 2011
Assessment of Day-to-Day Functioning in Prodromal and Early Huntington DiseaseAnthony L Vaccarino, Terrence Sills, Karen E Anderson, et al.
The Journal of Clinical Investigation|August 30, 2013
Metabolic network as a progression biomarker of premanifest Huntington's diseaseChris C Tang, Andrew Feigin, Yilong Ma, et al.
Journal of Huntington'S Disease|July 4, 2016
Health Care Delivery Practices in Huntington's Disease Specialty Clinics: An International SurveyJan C Frich, Daniela Rae, Richard Roxburgh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 22, 2019
Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studiesJunchao Tong, Belinda Williams, Pablo M Rusjan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriersAnthony L Vaccarino, Karen Anderson, Beth Borowsky, et al.
Pageof 7